CAH
53
3
EOG
49
2
TGNA
53
-3
PAYX
51
-3
PFE
25
-3
CMG
66
2
RL
80
-2
EMC
65
6
PFG
43
-2
GM
58
-3
UPS
51
-7
PEP
48
-5
IVZ
53
-2
D
43
-2
NRG
52
-2
DGX
39
2
FE
45
-3
ETR
63
-3
GOOG
63
-2
TXT
53
-2
CAH
53
3
EOG
49
2
TGNA
53
-3
PAYX
51
-3
PFE
25
-3
CMG
66
2
RL
80
-2
EMC
65
6
PFG
43
-2
GM
58
-3
UPS
51
-7
PEP
48
-5
IVZ
53
-2
D
43
-2
NRG
52
-2
DGX
39
2
FE
45
-3
ETR
63
-3
GOOG
63
-2
TXT
53
-2
Financhill
Back

Anheuser-Busch InBev SA/NV Vs. PTC Therapeutics Industry Stock Comparison

Buy
60

BUDFF
Anheuser-Busch InBev SA/NV

Last Price:
52.94
Seasonality Move:
-2.68%
Sell
47

PTCT
PTC Therapeutics

Last Price:
49.82
Seasonality Move:
17.12%
Buy
60
Anheuser-Busch InBev SA/NV (BUDFF) is a Buy

Is Anheuser-Busch InBev SA/NV a Buy, Sell or Hold?

  • The current Anheuser-Busch InBev SA/NV [BUDFF] share price is $53.50. The Score for BUDFF is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • BUDFF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
PTC Therapeutics (PTCT) is a Sell

Is PTC Therapeutics a Buy, Sell or Hold?

  • The current PTC Therapeutics [PTCT] share price is $50.29. The Score for PTCT is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • PTCT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BUDFF Stock Price Chart

What is Anheuser-Busch InBev SA/NV's stock price today?

  • The Anheuser-Busch InBev SA/NV share price today is $53.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BUDFF is experiencing selling pressure, which indicates risk of future bearish movement.

PTCT Stock Price Chart

What is PTC Therapeutics's stock price today?

  • The PTC Therapeutics share price today is $50.29
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTCT is experiencing selling pressure, which indicates risk of future bearish movement.

BUDFF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.01 Sell
Relative Strength Index (14 RSI): 30.62 Sell
Chaikin Money Flow: -6949 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.05 - 59.23) Sell
Bollinger Bands (100): (57.64 - 64.76) Sell

PTCT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.11 Buy
Relative Strength Index (14 RSI): 66.75 Buy
Chaikin Money Flow: -849912 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (40.04 - 46.16) Buy
Bollinger Bands (100): (32.47 - 41.53) Buy

BUDFF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.21 Sell
20-day SMA: 55.61 Sell
50-day SMA: 60.95 Sell
200-day SMA: 61.09 Sell
8-day EMA: 54.35 Sell
20-day EMA: 56.05 Sell
50-day EMA: 58.96 Sell
200-day EMA: 60.72 Sell

PTCT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.81 Buy
20-day SMA: 43.67 Buy
50-day SMA: 40.62 Buy
200-day SMA: 34.19 Buy
8-day EMA: 46.55 Buy
20-day EMA: 44.07 Buy
50-day EMA: 41.1 Buy
200-day EMA: 35.83 Buy

Anheuser-Busch InBev SA/NV Earnings Growth & BUDFF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

PTC Therapeutics Earnings Growth & PTCT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and an increase next year of $0.82 per share.

Anheuser-Busch InBev SA/NV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

PTC Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):